Health Technology · Pharmaceuticals: Major · NSE: ALPA · data 2026-10-09

Alpa Laboratories Limited

Health check: Average (4.3/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹56.99

Market cap

₹118 cr

P/E

27.4

P/B

—

ROE

8.4%

ROCE

0.7%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

-36.7%

52-week high

₹93.85

52-week low

₹46.1

Operating margin

-3.0%

Growth

Revenue (last 12 months)	₹111 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	4.4%
Profit growth, 3 years (yearly)	6.1%

Similar companies

Quest Laboratories Ltd. (QUESTLAB) · Parnax Lab Limited (PARNAXLAB) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Makers Laboratories Ltd (MAKERSL) · Sotac Pharmaceuticals Limited (SOTAC)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ALPA in NSE Scanner →